Clinical Trials Sponsored by Tiohundra AB

Total 984 results

SciBase AB

Completed

International Melanoma Algorithm Training Study - IMATS

Malignant Melanoma

Sweden
Curovir AB
CTC Clinical Trial Consultants AB

Completed

First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.

Pulmonary Disease, Chronic Obstructive | Enterovirus Infections | Rhinovirus

Sweden
PepTonic Medical AB
Pharma Consulting Group AB

Completed

Dose-relationship of Vaginally Administrated Oxytocin in Postmenopausal Women (OXYPEP002)

Vaginal Atrophy

Sweden
Arvid Carlsson Research AB
Gottfries Clinic AB

Completed

Study Evaluating Efficacy and Safety of OSU6162 in the Treatment of Residual Symptoms After Stroke (OSU6162DB003)

Stroke Sequelae

Sweden
Nanexa AB
CTC Clinical Trial Consultants AB

Completed

To Assess Safety, Tolerability and PK of NEX-20A, a Subcutaneous Prolonged-release Injection to Healthy Subjects

Multiple Myeloma

Sweden
Contract Research Organization el AB
Commitum AB

Completed

Sublingual Nicotine Tablets Compared With Swedish Snus

Smoking Cessation

Sweden
Kancera AB
LINK Medical Research AB; CRST Oy; Q&Q Labs AB

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145

Ovarian Cancer

Finland
Empros Pharma AB
CTC Clinical Trial Consultants AB

Active, not recruiting

Study Exploring the Supportive Effect of Acarbose in Weight Management

Overweight or Obesity

Sweden
Viscogel AB
Karolinska Institutet; Pharma Consulting Group AB

Completed

Single-center Study Evaluating the Safety and Efficacy of Viscogel® as Adjuvant in Act-HIB® Vaccine (VSG-2011-101)

Healthy

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users (SMWS03)

Smoking Cessation | Harm Reduction

Sweden
Empros Pharma AB
CTC Clinical Trial Consultants AB

Recruiting

A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

Overweight or Obesity

Sweden
Gesynta Pharma AB
CTC Clinical Trial Consultants AB

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-248

Healthy

Sweden
Vicore Pharma AB
CTC Clinical Trial Consultants AB

Completed

Effect of C21 on Forearm Blood Flow

Study Vasodilatory Effects of C21

Sweden
Karolinska Institutet
SOS Alarm Sverige AB; Everdrone AB

Completed

AED-delivery Using Drones in Out-of-hospital Cardiac Arrest

Out-Of-Hospital Cardiac Arrest

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus (SMWS03)

Smoking Cessation | Harm Reduction | Smokeless Tobacco

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

4 mg Nicotine Polacrilex Gum and Swedish Portion Snus (SMWS06)

Healthy Subjects | Smokers

Sweden
Gedea Biotech AB

Recruiting

A Randomised, Partly-blinded Investigation to Evaluate the Clinical Performance and Safety of pHyph in Adult Women With Bacterial Vaginosis Compared With an Untreated Control Group (Nefertiti 2)

Bacterial Vaginosis

Sweden
Hansa Biopharma AB

Recruiting

A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group (PAES-LTFU)

Long Term Efficacy and Safety

Spain, Czechia
Diamyd Medical AB

Recruiting

Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes

Autoimmune Diseases | Diabetes Mellitus, Type 1 | Prevention

Sweden
Xintela AB
Vinnova

Recruiting

A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers

Venous Leg Ulcer

Sweden
Ectin Research AB

Not yet recruiting

A Study of MFA-370 in Patients With Metastatic Urothelial Cancer (MANHATTAN)

Metastatic Urothelial Cancer

Sweden
Hansa Biopharma AB

Recruiting

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts (PAES)

Kidney Transplantation in Highly Sensitized Patients

Germany, Spain, Italy, France, Netherlands, Belgium, Austria, Czechia, Sweden, United Kingdom, Slovenia
Occlutech International AB

Recruiting

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases (mVSD Registry)

Muscular Ventricular Septal Defect

Turkey
Occlutech International AB

Recruiting

The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension (AFR-Prophet)

Pulmonary Hypertension

Germany, Netherlands, Poland, Turkey
Guard Therapeutics AB

Completed

A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery

Acute Kidney Injury (AKI)

Germany
Moberg Pharma AB

Completed

Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design (RIPT)

Erythema

United States
Ascelia Pharma AB

Completed

Safety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney Function (SPARKLE)

Severe Renal Impairment | Known or Suspected Focal Liver Lesions

United States, Italy, Germany, Poland, Russian Federation, Sweden, Turkey, Argentina, Colombia, Mexico
Hansa Biopharma AB

Completed

An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients

Kidney Transplant Rejection

Australia, United States, Germany, France, Austria
BioInvent International AB

Active, not recruiting

BI-1607 in Combination With Trastuzumab in Subjects With HER2-positive Advanced Solid Tumors (CONTRAST)

HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast Cancer

Spain, United Kingdom, Germany
AB Biotics, SA

Completed

Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients

Depressive Disorder, Major

Spain
Hansa Biopharma AB

Active, not recruiting

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

Kidney Transplantation in Highly Sensitized Patients

United States
Moberg Pharma AB

Active, not recruiting

A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Onychomycosis

United States, Canada
Occlutech International AB

Active, not recruiting

Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study (FROST-HF)

Heart Failure With Preserved Ejection Fraction (HFpEF) | Heart Failure With Reduced Ejection Fraction (HFrEF)

United States
Kontigo Care AB

Completed

A First Study in Healthy Volunteers of a New Mobile Phone Application Measuring the Eyes Before and After Medication

Drug Abuse

Netherlands
Xspray Pharma AB

Completed

Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects

Pharmacokinetics | Bioavailability

United Kingdom
Calliditas Therapeutics AB

Active, not recruiting

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE) (Nefigard-OLE)

Primary IgA Nephropathy

Sweden
Calliditas Therapeutics AB

Completed

Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy (Nefigard)

Primary IgA Nephropathy

United States, Australia, Taiwan, Spain, Canada, Argentina, Belarus, Belgium, Czechia, Finland, France, Germany, Greece, Italy, Korea, Republic of, Poland, Sweden, Turkey, United Kingdom
Vicore Pharma AB

Completed

A Trial to Evaluate the Impact of C21 on the Exposure of 4 Substrates in Healthy Volunteers

Drug Interaction

Sweden
Oriflame Cosmetics AB

Completed

Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation

Healthy | Skin Manifestations

Sweden
Hansa Biopharma AB

Terminated

An Long-term Follow-up Trial of Kidney Tx Patients Treated With Imlifidase or PE After an AMR

Kidney Transplant Rejection

Germany, France, Austria
Calliditas Therapeutics AB

Completed

Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects

Phase 1

France
Hansa Biopharma AB

Completed

A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test (Highdes)

Kidney Failure, Chronic

United States, Sweden, France
Athera Biotechnologies AB

Completed

Efficacy, Safety and Tolerability of ATH3G10 in Patients With ST-elevation Myocardial Infarction

ST Elevation Myocardial Infarction

Sweden
Galecto Biotech AB

Completed

A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Safety and Tolerability

United Kingdom
PepTonic Medical AB

Completed

Evaluation of VagiVital® for Treatment of Vaginal Atrophy

Vaginal Atrophy

Sweden
Isofol Medical AB

Completed

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Colonic Neoplasms

Sweden
Isofol Medical AB

Completed

Investigation of [6R] 5,10-methylenetetrahydrofolate (Arfolitixorin) as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.

Osteosarcoma

Poland, Czechia, Hungary, Sweden
Isofol Medical AB

Completed

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Rectal Cancer

Sweden
Occlutech International AB

Completed

Occlutech Septal Occluder (Figulla Flex II) Study

Secundum Atrial Septal Defects
Natumin Pharma AB

Completed

Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis

Tinea Pedis

Sweden

3

Subscribe